Uncategorized – Kinnov Therapeutics https://www.kinnov-therapeutics.com First-in-class therapy for a worldwide market Mon, 08 Feb 2016 12:06:09 +0000 en-US hourly 1 https://wordpress.org/?v=5.3.18 https://www.kinnov-therapeutics.com/wp-content/uploads/2015/12/cropped-favicon-1-32x32.png Uncategorized – Kinnov Therapeutics https://www.kinnov-therapeutics.com 32 32 New investigators for phase 2 clinical trial https://www.kinnov-therapeutics.com/new-investigators-for-phase-2-clinical-trial/ Mon, 08 Feb 2016 12:01:20 +0000 https://www.kinnov-therapeutics.com/?p=211 Prof. Henri-Jean Aubin, Hôpital Paul Brousse, Villejuif, accepts the function of Principal Investigator

Henri-Jean_Aubin
Dr. Ivan Berlin, Hôpital Pitié-Salpêtrière, Paris, accepts the function of Co-Investigator

ivan_berlin
Prof. Henri-Jean Aubin and Dr. Ivan Berlin, are internationally renowned for their competence in alcohol and tobacco addiction studies respectively.
They have accepted to be implicated in the phase 2 clinical trial for alcohol addiction.

]]> Welcome on our website https://www.kinnov-therapeutics.com/welcome-website/ Mon, 21 Dec 2015 14:35:19 +0000 https://www.kinnov-therapeutics.com/?p=1 The new Kinnov Therapeutics website is launched.

Welcome !

Feel free to contact us if you have any question.

]]> BPI France validates the Kinnov-Therapeutics project https://www.kinnov-therapeutics.com/bpi-france-validates-the-kinnov-therapeutics-project/ Tue, 08 Dec 2015 11:51:56 +0000 https://www.kinnov-therapeutics.com/?p=202 BPI FRANCE has validated the Kinnov-Therapeutics project in 2015 by supporting the phase 2 clinical trial.

bpifrance_logo

 

 

 

The Région Centre also participates to this adventure.

regioncentre_logo

 

 

 

More information about our goal.

]]>